Cohen et al. [119] performed an ethics committee (Alfred Hospital, Melbourne, Australia) retrospective audit of their tertiary referral clinic to evaluate real-world outcomes in adult patients with T1D who were using adjunctive therapy with GLP-1 RA for two or more visits. Here, GLP1R is linked to type 1 diabetes mellitus.